Prevention of Incisional Hernia With Mesh-suture at Umbilical Trocar Site.
NCT ID: NCT06251583
Last Updated: 2024-02-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
PHASE3
124 participants
INTERVENTIONAL
2023-03-22
2025-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The incidence of incisional trocar site hernia ranges from 20 to 35% of patients after laparoscopic surgery depending on the different investigations. Prophylactic meshes have been tried in an attempt to reduce the incidence of this complication in obese patients. In that sense, suture-meshes can be an alternative to conventional meshes to improve the incidence of incisional hernias.
INDURATE TRIAL aims to test if suture-mesh is capable of reducing the incidence of incisional hernia in patients with risk factors for the development of this frequent complication when compared with conventional monofilament sutures.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Trocar Site Incisional Hernia Prevention
NCT04699201
Prevention of Incisional Hernia With an Onlay Mesh Visible on MRI
NCT03105895
Long Term Results of Randomized Prospective Comparison of Onlay and Sublay Mesh Repair Techniques for Incisional Hernia
NCT02314091
Algorithm for Prophylactic Mesh Use in Emergency Laparotomy.
NCT04808063
Laparoscopic or Conventional Mesh Repair of Incisional and Umbilical Hernia
NCT00970515
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Experimental group or Duramesh group
Umbilical trocar closure using Suture-mesh (Duramesh suture).
duramesh suture
Duramesh-suture will be used for trocar closure in the experimental group
Control group or poli(4)hidroxibutirate group
Umbilical trocar closure using conventional monofilament suture.
duramesh suture
Duramesh-suture will be used for trocar closure in the experimental group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
duramesh suture
Duramesh-suture will be used for trocar closure in the experimental group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Umbilical trocar incision \> 10 mm
* Any of the following risk factors: BMI \> 27, Absence of primary umbilical hernia or smaller than 1 cm, active smoking, malnutrition, anemia, oncological surgery, diabetes, heart failure, chronic kidney disease, chronic liver disease, collagen disease, chronic pulmonary disease.
Exclusion Criteria
* Umbilical hernia \> 10 mm
* Hernia surgery or incisional hernia at the trocar site
* Conversion to laparotomy
* Pregnancy
* Ascites or cirrhosis
* Clasification of the American Anestesiology Classification IV o V.
* Inadequate follow-up
* Patients included in any other trial
* Patients with life expectancy \< 12 months
* Patients with any kind of sensibility to Duramesh
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ana Sánchez Gollarte
UNKNOWN
Álvaro Robin Valle de Lersundi
UNKNOWN
Arturo Cruz Cidoncha
UNKNOWN
Almudena Moreno Elola-Olaso
UNKNOWN
Armando Galván Pérez
UNKNOWN
Ana María Minaya Bravo
UNKNOWN
Enrique González González
UNKNOWN
Carlos Guijarro Moreno
UNKNOWN
Asunción Aguilera Velardo
UNKNOWN
Patricia López Quindos
UNKNOWN
Clara María Martínez Moreno
UNKNOWN
Marina Pérez-Flecha González
UNKNOWN
Victor Vaello Jodra
UNKNOWN
Miguel A ngel Garci-a Urena
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Miguel A ngel Garci-a Urena
Professor Miguel Ángel García Ureña
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Miguel Ángel García Ureña
Madrid, , Spain
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
INDURATE
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.